Long-Term Outcomes of Targeted Volume Overload Management in Patients With Severe Aortic Stenosis
Open Access
- 1 April 2026
- journal article
- Published by Elsevier in JACC: Advances
- Vol. 5 (5) , 102705
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration
This publication has 32 references indexed in Scilit:
- Multiorgan Dysfunction and its Association With Congestion and Outcome in Aortic Stenosis Treated With TAVIJACC: Advances, 2025
- Quantitative Fluid Overload in Severe Aortic Stenosis Refines Cardiac Damage and Associates with Worse OutcomesEuropean Journal of Heart Failure, 2023
- Heart failure with preserved ejection fraction after left‐sided valve surgery: prevalent and relevantEuropean Journal of Heart Failure, 2021
- Fluid Overload in Patients Undergoing TAVR: What We Can Learn from the NephrologistsESC Heart Failure, 2021
- Light-Chain and Transthyretin Cardiac Amyloidosis in Severe Aortic Stenosis: Prevalence, Screening Possibilities, and OutcomeEuropean Journal of Heart Failure, 2020
- Lung Ultrasound-Guided Treatment in Ambulatory Patients with Heart Failure: A Randomized Controlled Clinical Trial (LUS-HF Study)European Journal of Heart Failure, 2019
- Prevalence, Pattern and Clinical Relevance of Ultrasound Indices of Congestion in Outpatients with Heart FailureEuropean Journal of Heart Failure, 2019
- 2017 ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic StenosisJACC, 2017
- Fluid status and outcome in patients with heart failure and preserved ejection fractionInternational Journal of Cardiology, 2016
- Relation of Loop Diuretic Dose to Mortality in Advanced Heart FailureThe American Journal of Cardiology, 2006